OBJECTIVES: Expert consensus methodology was used to develop a medication treatment algorithm for attention-deficit/hyperactivity disorder (ADHD). The algorithm broadly outlined the choice of medication for ADHD and some of its most common comorbid conditions. Specific tactical recommendations were developed with regard to medication dosage, assessment of drug response, management of side effects, and long-term medication management. METHOD: The consensus conference of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families developed evidence-based tactics for the pharmacotherapy of childhood ADHD and its common comorbid disorders. The panel discussed specifics of treatment of ADHD and its comorbid conditions with stimulants, antidepressants, mood stabilizers, alpha-agonists, and (when appropriate) antipsychotics. RESULTS: Specific tactics for the use of each of the above agents are outlined. The tactics are designed to be practical for implementation in the public mental health sector, but they may have utility in many practice settings, including the private practice environment. CONCLUSIONS: Tactics for psychopharmacological management of ADHD can be developed with consensus.
OBJECTIVES: Expert consensus methodology was used to develop a medication treatment algorithm for attention-deficit/hyperactivity disorder (ADHD). The algorithm broadly outlined the choice of medication for ADHD and some of its most common comorbid conditions. Specific tactical recommendations were developed with regard to medication dosage, assessment of drug response, management of side effects, and long-term medication management. METHOD: The consensus conference of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families developed evidence-based tactics for the pharmacotherapy of childhood ADHD and its common comorbid disorders. The panel discussed specifics of treatment of ADHD and its comorbid conditions with stimulants, antidepressants, mood stabilizers, alpha-agonists, and (when appropriate) antipsychotics. RESULTS: Specific tactics for the use of each of the above agents are outlined. The tactics are designed to be practical for implementation in the public mental health sector, but they may have utility in many practice settings, including the private practice environment. CONCLUSIONS: Tactics for psychopharmacological management of ADHD can be developed with consensus.
Authors: John V Lavigne; Mina K Dulcan; Susan A LeBailly; Helen J Binns; Thomas K Cummins; Poonam Jha Journal: Pediatrics Date: 2011-06-13 Impact factor: 7.124
Authors: Patricia A Sirois; Lisa Aaron; Grace Montepiedra; Deborah A Pearson; Suad Kapetanovic; Paige L Williams; Patricia A Garvie; Molly L Nozyce; Kathleen Malee; Sharon L Nichols; Betsy L Kammerer; Wendy G Mitchell; Mark Mintz; James M Oleske Journal: Pediatr Infect Dis J Date: 2016-01 Impact factor: 2.129
Authors: Patricia A Sirois; Grace Montepiedra; Suad Kapetanovic; Paige L Williams; Deborah A Pearson; Kathleen Malee; Patricia A Garvie; Betsy L Kammerer; Sharon L Nichols; Molly L Nozyce; Mark Mintz; Wendy G Mitchell; James M Oleske Journal: J Dev Behav Pediatr Date: 2009-10 Impact factor: 2.225